 |
 |
Search
- Page Path
-
- HOME
- Search
- Endoscopy
- Reviewing not Homer’s Iliad, but “Kai Bao Ben Cao”: indigo dye—the past, present, and future
- Yusuke Yoshimatsu, Tomohisa Sujino, Takanori Kanai
- Intest Res. 2023;21(2):174-176. Published online June 14, 2022
- Full text PubReader ePub PDF
- Microbiota
- Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease
- Seung Yong Shin, Young Kim, Won-Seok Kim, Jung Min Moon, Kang-Moon Lee, Sung-Ae Jung, Hyesook Park, Eun Young Huh, Byung Chang Kim, Soo Chan Lee, Chang Hwan Choi, on behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases
- Intest Res. 2023;21(1):148-160. Published online June 14, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- Infection
- Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas
- Karan Sachdeva, Peeyush Kumar, Bhaskar Kante, Sudheer K. Vuyyuru, Srikant Mohta, Mukesh K. Ranjan, Mukesh K. Singh, Mahak Verma, Govind Makharia, Saurabh Kedia, Vineet Ahuja
- Intest Res. 2023;21(2):226-234. Published online June 13, 2022
- Full text PubReader ePub PDF
|
|
- IBD
- Clinical features of very early-onset inflammatory bowel disease in Japan: a retrospective single-center study
- Masaaki Usami, Ichiro Takeuchi, Reiko Kyodo, Yuri Hirano, Kosuke Kashiwagi, Hiroki Fujikawa, Hirotaka Shimizu, Toshinao Kawai, Katsuhiro Arai
- Intest Res. 2022;20(4):475-481. Published online June 13, 2022
- Full text PubReader ePub PDF
|
|
- Functional bowel disorder
- An Asian perspective on irritable bowel syndrome
- Kee Wook Jung, Seung-Jae Myung
- Intest Res. 2023;21(2):189-195. Published online May 31, 2022
- Full text PubReader ePub PDF
|
|
- IBD
- Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
- Soo-Young Na, Chang Hwan Choi, Eun Mi Song, Ki Bae Bang, Sang Hyoung Park, Eun Soo Kim, Jae Jun Park, Bora Keum, Chang Kyun Lee, Bo-In Lee, Seung-Bum Ryoo, Seong-Joon Koh, Miyoung Choi, Joo Sung Kim, on behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases
- Intest Res. 2023;21(1):61-87. Published online May 31, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- Miscellaneous
- Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies
- Priscila A. Lima, Bárbara B. Berg, Marina Gomes Miranda e Castor
- Intest Res. 2022;20(4):392-417. Published online May 31, 2022
- Full text PubReader ePub PDF
|
|
- IBD
- One-year clinical efficacy and safety of indigo naturalis for active ulcerative colitis: a real-world prospective study
- Yuichi Matsuno, Takehiro Torisu, Junji Umeno, Hiroki Shibata, Atsushi Hirano, Yuta Fuyuno, Yasuharu Okamoto, Shin Fujioka, Keisuke Kawasaki, Tomohiko Moriyama, Tomohiro Nagasue, Keizo Zeze, Yoichiro Hirakawa, Shinichiro Kawatoko, Yutaka Koga, Yoshinao Oda, Motohiro Esaki, Takanari Kitazono
- Intest Res. 2022;20(2):260-268. Published online April 29, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- Drug therapy and monitoring for inflammatory bowel disease: a multinational questionnaire investigation in Asia
- Chenwen Cai, Juntao Lu, Lijie Lai, Dongjuan Song, Jun Shen, Jinlu Tong, Qing Zheng, Kaichun Wu, Jiaming Qian, Zhihua Ran
- Intest Res. 2022;20(2):213-223. Published online April 29, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- Fecal S100A12 is associated with future hospitalization and step-up of medical treatment in patients with Crohn’s disease in clinical remission: a pilot study
- Sun-Ho Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
- Intest Res. 2022;20(2):203-212. Published online April 29, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- Perspectives of East Asian patients and physicians on complementary and alternative medicine use for inflammatory bowel disease: results of a cross-sectional, multinational study
- Eun Soo Kim, Chung Hyun Tae, Sung-Ae Jung, Dong Il Park, Jong Pil Im, Chang Soo Eun, Hyuk Yoon, Byung Ik Jang, Haruhiko Ogata, Kayoko Fukuhara, Fumihito Hirai, Kazuo Ohtsuka, Jing Liu, Qian Cao, on behalf of the Clinical Research Committee of the Asian Organization for Crohn’s and Colitis
- Intest Res. 2022;20(2):192-202. Published online April 29, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?
- Sang Hyoung Park
- Intest Res. 2022;20(2):159-164. Published online April 29, 2022
- Full text PubReader ePub PDF
|
|
- Is primary sclerosing cholangitis with inflammatory bowel disease different between patients in the East and West?
- Yong Eun Park
- Intest Res. 2022;20(2):157-158. Published online April 29, 2022
- Full text PubReader ePub PDF
|
|
- 0. Is fecal microbiota transplantation effective in corticosteroid-dependent ulcerative colitis?
- Published online April 29, 2022
-
|
|
- IBD
- Novel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD care
- Alex Barnes, David Carter, Patricia Kaazan, Alissa Walsh, Susan Connor, Jane M Andrews
- Intest Res. 2022;20(4):506-508. Published online April 26, 2022
- Full text PubReader ePub PDF
|
|
- Editorial Office
-
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145 Fax: +82-2-957-6146 E-mail: thekasid@irjournal.org
Copyright © 2024 by Korean Association for the Study of Intestinal Diseases.
